Neurogene Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Neurogene Inc. (NGNE) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.52 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11
- Neurogene Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 3.37M shares, a 28.83% increase year-over-year.
- Neurogene Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 2.62M shares, a 34.24% increase year-over-year.
- Neurogene Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-09-30 was 1.38M shares, a 98.71% decline year-over-year.
- Neurogene Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-06-30 was 1.50M shares, a 98.60% decline year-over-year.
- Neurogene Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 2.60M shares, a 39.61% increase from fiscal 2024.
- Neurogene Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.86M shares.
- Neurogene Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 8.94M shares, a 2.27% decline from fiscal 2021.
- Neurogene Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 9.15M shares, a 29.64% increase from fiscal 2020.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 0 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.52M shares 10-Q · filed 2026-08-11 | ||||||
| 2026-03-31 | 3.37M shares 10-Q · filed 2026-05-12 | ||||||
| 2025-12-31 | 2.60M shares 10-K · filed 2026-03-24 | ||||||
| 2025-09-30 | 2.63M shares 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | 2.66M shares 10-Q · filed 2026-08-11 | ||||||
| 2025-03-31 | 2.62M shares 10-Q · filed 2026-05-12 | ||||||
| 2024-12-31 | 1.86M shares 10-K · filed 2026-03-24 | ||||||
| 2024-09-30 | 1.38M shares 10-Q · filed 2024-11-18 | 1.86M shares 10-Q · filed 2025-11-13 | |||||
| 2024-06-30 | 1.50M shares 10-Q · filed 2024-08-09 | 1.98M shares 10-Q · filed 2025-08-11 | |||||
| 2024-03-31 | 1.95M shares 10-Q · filed 2025-05-09 | 1.48M shares 10-Q · filed 2024-05-10 | |||||
| 2023-12-31 | 541.18K shares 10-K · filed 2024-03-18 | ||||||
| 2023-09-30 | 106.91M shares 10-Q · filed 2024-11-18 | 902.31K shares 10-Q · filed 2023-11-14 | 902.31K shares 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | 106.92M shares 10-Q · filed 2024-08-09 | 4.69M shares 10-Q · filed 2023-08-10 | 4.69M shares 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | 106.92M shares 10-Q · filed 2024-05-10 | 5.38M shares 10-Q · filed 2023-05-08 | |||||
| 2022-12-31 | 8.94M shares 10-K · filed 2023-03-20 | ||||||
| 2022-09-30 | 1.99M shares 10-Q · filed 2023-11-14 | 9.93M shares 10-Q · filed 2022-11-14 | 1.99M shares 10-Q · filed 2023-11-14 | 9.93M shares 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | 8.32M shares 10-Q · filed 2023-08-10 | 8.32M shares 10-Q · filed 2023-08-10 | |||||
| 2022-03-31 | 9.05M shares 10-Q · filed 2023-05-08 | ||||||
| 2021-12-31 | 9.15M shares 10-K · filed 2023-03-20 | ||||||
| 2021-09-30 | 9.81M shares 10-Q · filed 2022-11-14 | 9.81M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 7.91M shares 10-Q · filed 2022-08-09 | 7.91M shares 10-Q · filed 2022-08-09 | |||||
| 2021-03-31 | 7.06M shares 10-Q · filed 2022-05-09 | ||||||
| 2020-12-31 | 7.06M shares 10-K · filed 2022-03-01 | ||||||
| 2020-09-30 | 6.97M shares 10-Q · filed 2021-11-04 | 6.97M shares 10-Q · filed 2021-11-04 | |||||
| 2020-06-30 | 5.76M shares 10-Q · filed 2021-08-05 | 5.76M shares 10-Q · filed 2021-08-05 | |||||
| 2020-03-31 | 5.48M shares 10-Q · filed 2021-05-12 | ||||||
| 2019-12-31 | 5.91M shares 10-K · filed 2021-03-25 | ||||||
| 2019-09-30 | 16.47M shares 10-Q · filed 2020-11-09 | 16.47M shares 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | 2.63M shares 10-Q · filed 2020-08-12 | 2.63M shares 10-Q · filed 2020-08-12 | |||||
| 2019-03-31 | 2.63M shares 10-Q · filed 2020-05-06 | ||||||
| 2018-12-31 | 2.90M shares 10-K · filed 2020-03-12 | ||||||
| 2018-09-30 | 3.36M shares 10-Q · filed 2019-11-13 | 3.36M shares 10-Q · filed 2019-11-13 | |||||
| 2018-06-30 | 2.74M shares 10-Q · filed 2019-08-01 | ||||||
| 2018-03-31 | 2.78M shares 10-Q · filed 2019-05-07 | ||||||
| 2017-12-31 | 2.07M shares 10-K · filed 2020-03-12 | ||||||
| 2017-09-30 | 2.07M shares 10-Q · filed 2018-11-07 | 2.07M shares 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | 2.06M shares 10-Q · filed 2018-08-08 | 2.06M shares 10-Q · filed 2018-08-08 | |||||
| 2017-03-31 | 2.02M shares 10-Q · filed 2018-05-08 | ||||||
| 2016-12-31 | 1.38M shares 10-K · filed 2019-03-07 | ||||||
| 2016-09-30 | 1.29M shares 10-Q · filed 2017-11-08 | 1.29M shares 10-Q · filed 2017-11-08 | |||||
| 2016-06-30 | 1.26M shares 10-Q · filed 2017-08-08 | 1.26M shares 10-Q · filed 2017-08-08 | |||||
| 2016-03-31 | 1.27M shares 10-Q · filed 2017-05-09 | ||||||
| 2015-12-31 | 876.82K shares 10-K · filed 2018-03-12 | ||||||
| 2015-09-30 | 870.32K shares 10-Q · filed 2016-11-09 | 870.32K shares 10-Q · filed 2016-11-09 | |||||
| 2015-06-30 | 1.08M shares 10-Q · filed 2016-08-04 | 1.07M shares 10-Q · filed 2015-08-06 | 1.08M shares 10-Q · filed 2016-08-04 | ||||
| 2015-03-31 | 1.07M shares 10-Q · filed 2016-05-10 | ||||||
| 2014-12-31 | 835.97K shares 10-K · filed 2017-03-09 | ||||||
| 2014-09-30 | 824.72K shares 10-Q · filed 2015-11-10 | 8.25M shares 10-Q · filed 2015-11-10 | 824.72K shares 10-Q · filed 2014-11-04 | ||||
| 2014-06-30 | 641.52K shares 10-Q · filed 2015-08-06 | 817.02K shares 10-Q · filed 2015-08-06 | |||||
| 2014-03-31 | 641.52K shares 10-Q · filed 2015-05-12 | ||||||
| 2013-12-31 | 6.18M shares 10-K · filed 2016-03-14 | ||||||
| 2013-09-30 | 6.04M shares 10-Q · filed 2014-11-04 | 6.04M shares 10-Q · filed 2014-11-04 | |||||
| 2013-06-30 | 6.04M shares 10-Q · filed 2014-08-11 | 6.04M shares 10-Q · filed 2014-08-11 | |||||
| 2013-03-31 | 5.96M shares 10-Q · filed 2014-05-13 | ||||||
| 2012-12-31 | 4.37M shares 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |